Agios Pharmaceuticals Appoints Paul J. Clancy to its Board of Directors
Published: Sep 26, 2013
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), today announced the addition of Paul J. Clancy, executive vice president and chief financial officer at Biogen Idec, to the company’s board of directors.
“As the CFO of a fully integrated, large cap biotechnology company, Paul brings invaluable experience to Agios following our successful IPO,” said David Schenkein, M.D., chief executive officer at Agios. “We expect that his unique perspective and relevant industry experience will be immediately beneficial to our team, and we believe his insights as an independent director will be particularly valuable as we continue to mature as a company.”
Help employers find you! Check out all the jobs and post your resume.